MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Clene Inc. Common Stock

CLNN

#4111
Clene Inc. Common Stock
6.7500 USD
+4.17%
Sector: Consumer Defensive
Base: USD
Profit Currency: USD
Daily Range
6.4700
6.7500
Year Range
4.3400
6.7850
Daily Change
+4.17%
Monthly Change
+18.42%
6 month change
+51.01%
Year Change
+51.01%
Previous Close
6.4800
Open
6.4700
Bid
Ask
Low
6.4700
High
6.7500
Volume
19
  1. Markets
  2. US Stock Market
  3. Consumer Defensive
  4. CLNN
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 79.5036 M
  • Employee 79
  • Founded 2013
  • CEO N/A
  • Website www.clene.com
  • Headquarter Delaware, United States
  • FIGI BBG00X3GTK66
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
79.5 M Market capitalization
Price to earnings ratio
-2.21
Price to sales ratio
289.36

News

Investing Investing
CLNN
2026.01.21
Clene Inc. ten percent owner sells $161k in shares
Investing Investing
CLNN
2026.01.12
Clene Inc. ten percent owner sells $256k in shares
Investing Investing
CLNN
2026.01.12
FDA grants Clene in-person meeting to discuss ALS drug biomarker data
Investing Investing
CLNN
2026.01.09
Clene secures $28 million in registered direct offering for ALS drug
Investing Investing
CLNN
2026.01.07
Clene Inc. ten percent owner Ugwumba sells $78k in shares
Investing Investing
CLNN
2025.12.31
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123
Investing Investing
CLNN
2025.12.31
Clene Inc: Ugwumba sells $73k in CLNN stock
Investing Investing
CLNN
2025.12.04
Benchmark reiterates Buy rating on Clene stock amid positive biomarker data
Investing Investing
CLNN
2025.11.20
Clene stock holds Buy rating at Benchmark as ALS drug nears FDA submission
Zacks Zacks
CLNN
2025.11.13
Clene Inc. (CLNN) Reports Q3 Loss, Lags Revenue Estimates
Zacks Zacks
OCS CLNN
2025.11.10
Oculis Holding AG (OCS) Reports Q3 Loss, Beats Revenue Estimates
Zacks Zacks
CCCC CLNN
2025.11.06
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Beats Revenue Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
MQL5 Channels
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Economic Calendar
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd